A Clinical Utility Study of PrismRA for Rheumatoid Arthritis

Inclusion Criteria: * Age ≥ 18 at time of consent * Patient must meet the criteria for RA as defined by the 2010 ACR/EULAR classification at Visit 1 * Patient has active, moderate to high, RA with a CDAI of \>10 at Visit 1 * Patient has swollen and tender joint count of ≥ 2 each, as determined by CDAI assessment at Visit 1 using a 28-joint count * Patient may participate in additional observational studies concurrently * Patient is willing and able to complete the informed consent process and comply with study procedures and visit schedule Exclusion Criteria: * Patients who are unable to understand the protocol and unable to provide informed consent * Patients who are not indicated for PrismRA * Patients who are receiving concurrent treatment with an investigational therapy or have used an investigational therapy less than 4 weeks prior to Visit 1